Northern Trust’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-95
Closed -$17.2K 4448
2024
Q2
$17.2K Hold
95
﹤0.01% 4342
2024
Q1
$10.5K Hold
95
﹤0.01% 4387
2023
Q4
$12.6K Hold
95
﹤0.01% 4405
2023
Q3
$11.5K Sell
95
-14
-13% -$1.95K ﹤0.01% 4390
2023
Q2
$22.5K Buy
109
+14
+15% +$2.73K ﹤0.01% 4388
2023
Q1
$17.3K Hold
95
﹤0.01% 4472
2022
Q4
$7.3K Hold
95
﹤0.01% 4605
2022
Q3
$9K Buy
+95
New +$11.8K ﹤0.01% 4653
2021
Q3
Sell
-59
Closed -$59K 4734
2021
Q2
$59K Sell
59
-5
-8% -$5.44K ﹤0.01% 4463
2021
Q1
$94K Buy
64
+19
+42% +$33.5K ﹤0.01% 4289
2020
Q4
$58K Hold
45
﹤0.01% 4217
2020
Q3
$63K Buy
45
+34
+309% +$54.7K ﹤0.01% 4069
2020
Q2
$16K Sell
11
-62
-85% -$99K ﹤0.01% 4190
2020
Q1
$92K Buy
73
+15
+26% +$71.9K ﹤0.01% 3832
2019
Q4
$378K Buy
58
+29
+100% +$143K ﹤0.01% 3624
2019
Q3
$150K Buy
29
+18
+164% +$276K ﹤0.01% 3830
2019
Q2
$255K Buy
+11
New +$279K ﹤0.01% 3754

Other funds holding SONM

Northern Trust's SONM Position: Q3 2024 in Review

Northern Trust sold out of DNA X Inc (SONM) in Q3 2024, closing a stake of 95 shares — an estimated $17.2K sold.

Northern Trust first reported a position in SONM in Q2 2019 and held it in 17 quarters. The position peaked at $378K in Q4 2019. 8 funds tracked by Wall St. Rank hold SONM as of Q3 2024.

  • Northern Trust reported no remaining DNA X Inc position as of Q3 2024 after selling out during the quarter.
  • Northern Trust sold 95 DNA X Inc shares in Q3 2024, an estimated $17.2K.
  • Northern Trust first reported a position in DNA X Inc in Q2 2019 and held it in 17 quarters.
  • Northern Trust's DNA X Inc position peaked at $378K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.